Table 1.
Patients divided as below and above median serum cancer antigen 125 (SeCa125).
| All N (489) | Serum Ca 125 below median (n = 238) | Serum Ca125 above median (n = 236) | p-Value | |
|---|---|---|---|---|
| Age | 62 (50–75) | 58 (49–72) | 66.5 (52.78) | 0.01 |
| Gender (male) | 295 (60.3%) | 167 (70.2%) | 120 (50.8%) | <0.001 |
| Diabetic (%) | 214/474 (45.1%) | 99 (41.6%) | 115 (48.7%) | 0.12 |
| PD modality | ||||
| APD | 102 (21.4%) | 65 (27.3%) | 33 (14.2%) | <0.001 |
| CAPD | 241 (50.5%) | 125 (52.5%) | 108 (46.4%) | |
| CCPD | 134 (28.1%) | 40 (16.8%) | 92 (39.5%) | |
| PD treatment months | 14 (3–29) | 14 (3–18) | 12 (3–29) | 0.42 |
| PET-UF volume (ml) | 250 (100–400) | 300 (200–400) | 200 (100–300) | <0.001 |
| Icodextrin used | 372 (76.1%) | 166/238 | 196/236 | <0.01 |
| 22.7g/L dextrose used | 268 (54.9%) | 135/238 | 126/235 | 0.49 |
| Weekly Kt/Vurea PD | 1.18 (0.89–1.51) | 1.23 (0.96–1.52) | 1.15 (0.80–1.51) | 0.06 |
| Weekly Kt/Vurea urine | 0.69 (0.17–1.3) | 0.63 (0.16–1.2) | 0.75 (0.20–1.47) | 0.06 |
| 24-hour peritoneal ultrafiltration (mL) | 676 (314–1073) | 676 (355–1134) | 674 (291–1003) | 0.25 |
| PET transporter status | ||||
| Slow | 37/462 (8%) | 23/227 (10.1%) | 13/222 (5.9%) | 0.04 |
| Medium | 274/462 (59.3%) | 148/227 (65.2%) | 117/222 (52.7%) | |
| Fast | 151/462 (32.7%) | 56/227 (24.7%) | 92/222 (41.4%) | |
| Haemoglobin (g/dL) | 10.9 (9.8–11.9) | 10.9 (9.9–11.9) | 10.9 (9.8–11.9) | 0.24 |
| Albumin (g/L) | 37 (33–40) | 38 (35–41) | 36 (32–39) | <0.001 |
| NT-proBNP (pg/mL) | 5032.6 (1504.3–18585.1) | 4069 (1344.7–12291.0) | 6870.0 (1936.6–20096.2) | 0.03 |
| CRP mg/L | 5 (2–13) | 5 (1–11) | 5 (2–17.5) | 0.03 |
| ECW/ TBW ratio | 0.399 (0.38–0.407) | 0.395 (0.387–0.407) | 0.403 (0.394–0.410) | <0.001 |
| LV ejection fraction | 57.0% (47.5–57.5%) | 57.0% (52.5–57.5%) | 55 (42.5–57.5%) | 0.01 |
PD: peritoneal dialysis; APD: automated peritoneal dialysis with dry day; CAPD: continuous ambulatory peritoneal dialysis; CCPD: automated peritoneal dialysis with wet day; PET: peritoneal equilibrium test; UF: ultrafiltration volume; NT-proBNP: N-terminal brain natriuretic peptide; CRP: C-reactive protein; ECW/TBW: ratio of extracellular to total body water; LV: echocardiogram left ventricular; ejection fraction.
Data reported as integer, percentage, mean ± standard deviation, median (interquartile range).